☆ 4.5 Editorial Material

PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates

JOURNAL OF CARDIAC FAILURE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis

Brett W. Sperry et al.

Summary: This study analyzed the association between IVUS measurements post-heart transplantation and adverse outcomes, and found that DTA and rapidly progressive CAV were not associated with medium- to long-term adverse events after heart transplantation.

JOURNAL OF CARDIAC FAILURE (2021)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Safety and Efficacy of PCSK9 Inhibitors After Heart Transplantation

Yasbanoo Moayedi et al.

CANADIAN JOURNAL OF CARDIOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Treatment of hypercholesterolaemia with PCSK9 inhibitors in patients after cardiac transplantation

Michael Kuehl et al.

PLOS ONE (2019)

添加到收藏夹

Editorial Material Immunology

Safety and Efficacy of PCSK9 Inhibitor Treatment in Heart Transplant Patients

Concetta Di Nora et al.

TRANSPLANTATION (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cardiovascular Outcomes of PCSK9 Inhibitors: With Special Emphasis on Its Effect beyond LDL-Cholesterol Lowering

Dhrubajyoti Bandyopadhyay et al.

JOURNAL OF LIPIDS (2018)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

Maria Rosa Costanzo et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins

K Shimizu et al.

CIRCULATION (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.